156
Participants
Start Date
August 2, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
AB-2004
Taken 3 times daily with food
Placebo
Take 3 times daily with food
Optimal Clinical Trials, Grafton
Brain Mind Centre, Sydney
Westmead Children's Hospital, Sydney
Murdoch Children's Research Institute, Parkville
Monash Kids Research, Clayton
Children's Health Queensland Hospital, South Brisbane
Spectrum Neuroscience and Treatment Institute, New York
Nathan S. Kline Institute for Psychiatric Research, Orangeburg
CNS Solutions, Jacksonville
CNS Solutions, Orlando
University of South Florida, Tampa
Harmonex Neuroscience Research, Dothan
Vanderbilt University Medical Center, Nashville
Ohio State University, Columbus
Baber Research, Naperville
University of Missouri, Thompson Center for Autism and Neurodevelopmental Disorders, Columbia
Relaro Medical Trials, Dallas
IMMUNOe Research Centers, Centennial
Southwestern Autism Research and Resource Center, Phoenix
University of Arizona, Tucson
Clinical Research of Southern Nevada, Las Vegas
Cortica Westlake, Westlake Village
Cortica Marin, San Rafael
Yale University, New Haven
Lead Sponsor
Axial Therapeutics, Inc.
INDUSTRY